SCHEMBL8610425

SCHEMBL8610425

CC=CC=CC(=O)OC1=CCOC=C1

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
EDNRA P25101 3/20 0.32
LMNA P02545 1/20 0.32
MAPK1 P28482 1/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8610422 1.00 EDNRA (0.32) EDNRALMNAMAPK1HTT
SCHEMBL2241925 0.67
SCHEMBL4364436 0.64 MAOB (0.48) LMNAMAPK1HTT
SCHEMBL27149 0.64 MAOB (0.48) LMNAMAPK1HTT
SCHEMBL8534568 0.63
SCHEMBL8534570 0.63
SCHEMBL17138213 0.63 KMT2A (0.47) LMNAMAPK1HTT
SCHEMBL17138211 0.63 KMT2A (0.47) LMNAMAPK1HTT
SCHEMBL27987849 0.63 MAOB (0.47) LMNAMAPK1HTT
SCHEMBL28066691 0.63 STAT3 (0.43) LMNAMAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5770382-A RETINOIC ACID AND RETINOID X RECEPTOR AGONISTS; TREATINGSKIN, EYE, BRAIN, AND CARDIOVASCULAR DISORDERS; CANCER LIGAND PHARMACEUTICALS, INC. (US) 1998-06-23 US disclosed
US-5770378-A A VITAMINE A METABOLITE, POTENT DRUGS TREATING SKIN DISEASES, CANCER, EYE DISEASES, CARDIOVASCULAR DISORDERS LIGAND PHARMACEUTICALS, INC. (US) 1998-06-23 US disclosed
US-5770383-A ACTIVATE RETINOID RECEPTORS LIGAND PHARMACEUTICALS, INC. (US) 1998-06-23 US disclosed